CIK 0001001233
- Non-accelerated filer
- Smaller reporting company
SANGAMO THERAPEUTICS, INC
Sign in to watch- Ticker
- SGMOQ
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680359556
- Phone
- +1 510-970-6000
- Business address
- 501 CANAL BLVD., RICHMOND, CA, 94084
- Former names
- SANGAMO BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-25 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −12,613 | $0.17 | $2K | 1,895,043 |
| 2026-04-01 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Grant or award · Stock Option (Right to Buy) | +2,500,000 | 2,500,000 | ||
| 2026-02-25 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −33,637 | $0.47 | $16K | 1,907,656 |
| 2026-02-24 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −5,291 | $0.47 | $2K | 1,941,293 |
| 2026-01-22 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −102,950 | $0.40 | $41K | 1,946,584 |
| 2025-11-24 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −7,488 | $0.42 | $3K | 2,049,534 |
| 2025-10-22 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −126,950 | $0.66 | $84K | 2,057,022 |
| 2025-08-24 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −7,488 | $0.59 | $4K | 2,183,972 |
| 2025-07-22 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −126,950 | $0.48 | $61K | 2,191,460 |
| 2025-05-24 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −7,488 | $0.47 | $4K | 2,318,410 |
| 2025-04-22 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −126,950 | $0.78 | $99K | 2,325,898 |
| 2025-02-25 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −10,663 | $0.96 | $10K | 2,077,848 |
| 2025-02-25 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Grant or award | +375,000 | 2,452,848 | ||
| 2025-02-25 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Grant or award · Stock Option (Right to Buy) | +1,750,000 | 1,750,000 | ||
| 2025-02-24 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −7,488 | $1.00 | $7K | 2,088,511 |
| 2025-01-22 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −412,584 | $1.15 | $474K | 2,095,999 |
| 2024-11-25 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −10,642 | $1.94 | $21K | 2,508,583 |
| 2024-11-24 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −7,473 | $1.88 | $14K | 2,519,225 |
| 2024-08-25 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −7,492 | $0.86 | $6K | 2,526,698 |
| 2024-08-24 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −5,261 | $0.86 | $5K | 2,534,190 |
Page 1 of 2 · 37 trades